![Sten Randahl Sörensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sten Randahl Sörensen
Directeur Général chez
CERENO SCIENTIFIC AB
Fortune : 686 127 $ au 31/05/2026
Profil
Sten Randahl Sörensen is currently Chief Executive Officer & Director at Cereno Scientific AB since 2015, Chairman at SARomics Biostructures AB since 2013, and Director at SynAct Pharma AB since 2024.
Former positions include Chairman at AcuCort AB, Chairman at Stayble Therapeutics AB, Director-Secondary Prevention Products Marketing at AstraZeneca AB, and Head-International Marketing Operations at Monsanto Crop Sciences Sweden AB from 1987 to 1995.
Education includes undergraduate studies at the University of Lund.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 1 128 514 ( 0,36 % ) | 653 285 $ | 31/05/2026 | |
SYNACT PHARMA AB 0,03 % | 31/12/2024 | 17 407 ( 0,03 % ) | 32 841 $ | 31/05/2026 |
Postes actifs de Sten Randahl Sörensen
| Sociétés | Poste | Début |
|---|---|---|
| CERENO SCIENTIFIC AB | Directeur Général | 01/09/2015 |
| SYNACT PHARMA AB | Directeur/Membre du Conseil | 20/03/2024 |
SARomics Biostructures AB
 SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Président | 01/01/2013 |
Anciens postes connus de Sten Randahl Sörensen
| Sociétés | Poste | Fin |
|---|---|---|
Monsanto Crop Sciences Sweden AB | Sales & Marketing | 01/01/1995 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Sales & Marketing | - |
| STAYBLE THERAPEUTICS AB | Président | - |
| ACUCORT AB | Président | - |
Formation de Sten Randahl Sörensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monsanto Crop Sciences Sweden AB | |
AcuCort AB
 AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Stayble Therapeutics AB
 Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
